Expand what's possible with protein-based biomarker diagnostics
Harnessing protein-based solutions for a new approach to health. Our range of Promarker®tests enable early, predictive, and life-saving diagnostics.
The blood test to predict the risk of diabetes-related CKD up to four years before symptoms appear.
The blood test that detects specific protein changes to rule out esophageal adenocarcinoma in your patient.
The blood test for an early diagnosis of endometriosis.
What is proteomics?
Proteomics is the large-scale mapping of the structure and function of proteins.
Unlike our genes, the protein make-up in our bodies differs from cell to cell and changes considerably over time. For example, a cancerous cell will have significantly different proteins to a healthy cell.
The caterpillar and butterfly have exactly the same genes but differences in their proteins cause dramatic differences during the lifecycle.
Clinical Performance of the PromarkerEso Blood Test For diagnosing Early Stage Esophageal Adenocarcinoma and Barrett’s Esophagus with High-Grade Dysplasia
See More
Jul 2025
Analytical and Clinical Performance of a Novel Immunoassay-Based Test System to Predict Diabetic Kidney Disease
See More
Jul 2025
The Level of Thiol-Oxidised Plasma Albumin Is Elevated Following a Race in Australian Thoroughbred Horses
See More
.png)
.png)
.png)
.png "Line 14 (1)")
